Evidence map›Paper›PMID 25928796›Full record

ArticleCritical care (London, England)2015

Integration of metabolic and inflammatory mediator profiles as a potential prognostic approach for septic shock in the intensive care unit.

Beata Mickiewicz, Patrick Tam, Craig N Jenne, Caroline Leger, Josee Wong, Brent W Winston, Christopher Doig, Paul Kubes, Hans J Vogel, Alberta Sepsis Network

Abstract read
In one paragraph

Article in Critical care (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Multi-Omics and -Organ Insights into Energy Metabolic Adaptations in Early Sepsis Onset.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Gut mycobiome dysbiosis after sepsis and trauma.Critical care (London, England) · 2024
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Beata MickiewiczBio-NMR-Centre, Department of Biological Sciences, University of Calgary, 2500 University Drive Northwest, Calgary, AB, T2N 1N4, Canada. bmmickie@ucalgary.ca.
Patrick TamSnyder Translational Laboratory, Department of Critical Care Medicine, University of Calgary, 3280 Hospital Drive Northwest, Calgary, AB, T2N 4N1, Canada. tam.patrickpc@gmail.com.
Craig N JenneSnyder Translational Laboratory, Department of Critical Care Medicine, University of Calgary, 3280 Hospital Drive Northwest, Calgary, AB, T2N 4N1, Canada. cnjenne@ucalgary.ca.
Caroline LegerSnyder Translational Laboratory, Department of Critical Care Medicine, University of Calgary, 3280 Hospital Drive Northwest, Calgary, AB, T2N 4N1, Canada. legercaroline@yahoo.ca.
Josee WongCritical Care Epidemiologic and Biologic Tissue Resource, Department of Critical Care Medicine, University of Calgary, 3280 Hospital Drive Northwest, Calgary, AB, T2N 4N1, Canada. jfwong@ucalgary.ca.
Brent W WinstonCritical Care Epidemiologic and Biologic Tissue Resource, Department of Critical Care Medicine, University of Calgary, 3280 Hospital Drive Northwest, Calgary, AB, T2N 4N1, Canada. bwinston@ucalgary.ca.
Christopher DoigDepartment of Community Health Sciences, University of Calgary, 3280 Hospital Drive Northwest, Calgary, AB, T2N 4N1, Canada. cdoig@ucalgary.ca.
Paul KubesSnyder Institute for Chronic Diseases, University of Calgary, 3280 Hospital Drive Northwest, Calgary, AB, T2N 4N1, Canada. pkubes@ucalgary.ca.
Hans J VogelBio-NMR-Centre, Department of Biological Sciences, University of Calgary, 2500 University Drive Northwest, Calgary, AB, T2N 1N4, Canada. vogel@ucalgary.ca.
Alberta Sepsis Network

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSeptic shock is a major life-threatening condition in critically ill patients and it is well known that early recognition of septic shock and expedient initiation of appropriate treatment improves patient outcome. Unfortunately, to date no single compound has shown sufficient sensitivity and specificity to be used as a routine biomarker for early diagnosis and prognosis of septic shock in the intensive care unit (ICU). Therefore, the identification of new diagnostic tools remains a priority for increasing the survival rate of ICU patients. In this study, we have evaluated whether a combined nuclear magnetic resonance spectroscopy-based metabolomics and a multiplex cytokine/chemokine profiling approach could be used for diagnosis and prognostic evaluation of septic shock patients in the ICU.

methodsSerum and plasma samples were collected from septic shock patients and ICU controls (ICU patients with the systemic inflammatory response syndrome but not suspected of having an infection). (1)H Nuclear magnetic resonance spectra were analyzed and quantified using the targeted profiling methodology. The analysis of the inflammatory mediators was performed using human cytokine and chemokine assay kits.

resultsBy using multivariate statistical analysis we were able to distinguish patient groups and detect specific metabolic and cytokine/chemokine patterns associated with septic shock and its mortality. These metabolites and cytokines/chemokines represent candidate biomarkers of the human response to septic shock and have the potential to improve early diagnosis and prognosis of septic shock.

conclusionsOur findings show that integration of quantitative metabolic and inflammatory mediator data can be utilized for the diagnosis and prognosis of septic shock in the ICU.

Indexed as

Intensive Care UnitsAgedBiomarkersFemaleHumansInflammation MediatorsMaleMetabolomeMiddle AgedPrognosisShock, SepticBiomarkersInflammation Mediators

Identifiers

PMID25928796
PMCPMC4340832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.